Expert Perspectives on Generalized Pustular Psoriasis

Michael Payette, MD, MBA, FAAD provides an overview of generalized pustular psoriasis, highlighting the challenges in the diagnosis of patients with this condition.

Dr Michael Payette discusses the patient QoL impacts and burden of generalized pustular psoriasis.

An expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.

Raj Chovatiya, MD, PhD, provides an overview of the factors he uses to lead to a diagnosis of generalized pustular psoriasis (GPP).

An expert dermatologist reviews the currently available agents for treatment of GPP and highlights the unmet needs in this space.

Dr Raj Chovatiya discusses a recently approved therapeutic agent, spesolimab, as a valuable addition to the GPP treatment landscape.

David Kaplan, MD, provides an overview of generalized pustular psoriasis, and comments on his differential diagnosis process and key symptomology.

Dr David Kaplan discusses the current treatment options for GPP; highlighting the long time to treatment repose, need for combination treatment, and of standard of care guidelines.

An expert in dermatology shares his thoughts on the educational and unmet needs in the identification and management of patients with GPP.